pharmaceutical impurity analysis solutions - Lcms-connect.com

More documents

Recommendations

Info

Learn morewww.agilent.com/lifescience/pharmaFind a local Agilent customer centerwww.agilent.com/chem/contactusUSA and Canada1-800-227-9770agilent_inquiries@agilent.comEuropeinfo_agilent@agilent.comAsia Pacificinquiry_lsca@agilent.comFor Research Use Only. Not for use in diagnostic procedures.This information is subject to change without notice.© Agilent Technologies, Inc. 2012Printed in the USA, April 19, 20125991-0090EN
Page 1: PHARMACEUTICAL IMPURITYANALYSIS SOL
Page 4 and 5: 1PHARMACEUTICAL IMPURITY ANALYSIS -
Page 6 and 7: should be avoided. Class II solvent
Page 8 and 9: 2ANALYTICAL TECHNOLOGIES FOR IMPURI
Page 10 and 11: Liquid Chromatography andUltraviole
Page 12 and 13: Supercritical FluidChromatography (
Page 14 and 15: Gas Chromatography (GC)7890A/5975C
Page 16 and 17: 3.1ANALYSIS OF ORGANIC IMPURITIESAc
Page 18 and 19: The advantage of using ISET’s sea
Page 20 and 21: Improve profiling productivityfor t
Page 22 and 23: AmAU40Chlorhexidine, spiked with 1
Page 24 and 25: 3.2ANALYSIS OF INORGANIC IMPURITIES
Page 26 and 27: 3.3RESIDUAL SOLVENT ANALYSISFaster
Page 28 and 29: Agilent Residual SolventAnalysis Pu

pharmaceutical impurity analysis solutions - Lcms-connect.com

Create successful ePaper yourself

Delete template?

Save as template?